Lu Guo
Hangzhou, 310000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
A DNA Aptamer as a Chemical Tool to Modulate MEX3C-Mediated mRNA Destabilization.
Journal: ACS applied bio materials
Published: January 10, 2026
SPARK-seq: A high-throughput platform for aptamer discovery and kinetic profiling.
Journal: Science (New York, N.Y.)
Published: January 01, 2026
Deep learning-based multimodal pathogenomics integration for precision cancer prognosis.
Journal: Journal of translational medicine
Published: September 17, 2025
Interferon-Driven Biomarkers and Synergistic Therapy for PRMT5 Inhibition in Triple-Negative Breast Cancer.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: April 01, 2025
PTf-SRiApt Targeting SCAF4-POLR2A Interaction Suppresses Tumor Growth and Promotes Antitumor Immunity in Triple-Negative Breast Cancer.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: January 08, 2025
Increasing RB1 Expression by Targeting EZH2 in Triple-Negative Breast Cancer.
Journal: Journal of cellular and molecular medicine
Published: May 27, 2024
Molecular classification of geriatric breast cancer displays distinct senescent subgroups of prognostic significance.
Journal: Molecular therapy. Nucleic acids
Published: March 05, 2024
A chemical screen identifies PRMT5 as a therapeutic vulnerability for paclitaxel-resistant triple-negative breast cancer.
Journal: Cell chemical biology
Published: November 27, 2023
Type-I protein arginine methyltransferase inhibition primes anti-programmed cell death protein 1 immunotherapy in triple-negative breast cancer.
Journal: Cancer
Published: September 20, 2023
Showing 1-9 of 9
Last Updated: 09/26/2026